Loading…
ENDATA>
ENDATARoyal Philips won a $450 million contract from the U.S. Department of Defense to supply patient monitoring systems, accessories and training to the Army, Navy, Air Force, Marine Corps and other federal agencies.
Ypsomed and Royal Philips announced a collaboration to jointly develop and deploy new digital self-medication adherence monitoring services based on Ypsomed's connected devices and Philips' HealthSuite Digital Platform.
Royal Philips acquired Xhale Assurance Inc, a US-based developer of next-generation sensor technologies including a disposable pulse oximetry sensor. Financial details were not disclosed.
Royal Philips acquired NightBalance, a Dutch digital health scale-up that developed the Sleep Position Trainer for positional obstructive sleep apnea. Financial details were not disclosed.
Digirad Corp. closed the sale of its medical device sales and service business and associated contracts to Royal Philips for $8 million. The divested business provides post-warranty maintenance for large diagnostic imaging equipment in the upper mid-west US.
Medtronic and Royal Philips entered a business relationship to develop and commercialize the LungGPS Patient Management Platform for managing lung nodule patients from identification through treatment.
Royal Philips and HeartFlow entered into a collaboration agreement to promote HeartFlow's FFRct Analysis with Philips' coronary catheters, initially focusing on the United States.
Profound Medical closed its $6 million acquisition of Royal Philips' Sonalleve MR-HIFU business, which features real-time MR imaging and high intensity focused ultrasound for tissue ablation.
Royal Philips agreed to widen its partnership with Profound Medical, transferring its Sonalleve MR-HIFU ultrasound business to Profound Medical and acquiring a 12% minority interest (7.4 million common shares). The transaction is expected to close in H2 2017.
Royal Philips has agreed to acquire The Spectranetics Corporation for $38.50 per share in cash, implying an enterprise value of approximately €1.9 billion. The acquisition will expand Philips' image-guided therapy business.